American Cannabis Ready for Investment?

American CannabisCannabis stocks experienced a surge on the market last year, before cooling off during a period of volatility in the last quarter. While stocks haven’t quite matched their peaks of 2018, there is still opportunity for long term growth. American Cannabis Co. Inc. (OTC: AMMJ) is a bargain penny stock with exciting potential.

The company operates in the medical cannabis sector, offering consulting, marketing, branding, equipment fulfilment, operational management, and regulatory compliance services. The newly found cannabis market in America needs companies like American Cannabis Co. for support. Business and regulatory expertise is in high demand.

The company has had some impressive performance in recent years. In 2015, the company grew its revenue by 122.39%. In the most recent fiscal year, revenue increased 56.52%, with gross income growth of 88.34%. With services based on consultancy rather than manufacturing and development, profit margin is above 67%. This is an interesting stock pick because the company could continue to grow as the cannabis market matures.

Key Data:

  • 1 Year Price Growth:    -45.07%
  • YTD Price Growth:        03%
  • 3 Month Price Growth: 28%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.


The reports, research and newsletter are based on current and historical market data, as well as publicly available financial data.They are intended to be a starting point for investors. They do not provide every material fact about a company or industry, nor are they recommendations to buy or sell. The writers and the company make no warranties or representations as to the accuracy of these reports.   You should NOT rely solely upon the information or opinions read in the content. Rather, you should use the content as a starting point for doing independent research on the independent analysis and trading methods in the content. The content is impersonal and does not provide individualized advice or recommendations for any specific reader or individual portfolio. By accessing this website you have agreed to our disclaimers and privacy policy.


You May Also Like

About the Author: Writocity